UroToday - The Global Online Community of Urologists

High Grade Non-Muscle Invasive Bladder Cancer and BCG Refractory Patient - Josh Meeks

September 21, 2018

Optimizing ADT in Prostate Cancer Patients - Tom Keane

September 17, 2018

Kidney Cancer

CARMENA: Practice Changing Strategies for Kidney Cancer

August 30, 2018

Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer (mCRPC) for Black versus White Men-Susan Halabi

July 25, 2018

Updates on Health-Related Quality-of-Life (HRQoL) analyses in GU Oncology - Cora Sternberg

July 24, 2018

Nocturia & Lower Urinary Tract Conditions

Nocturia in the Aging Patient, Assessment and Treatment- Susann Varano

July 16, 2018

Genetic Evaluation and Counseling in Prostate Cancer Treatment - Interview with Heather Cheng

June 27, 2018

The State of Nuclear Medicine in the Treatment of Prostate Cancer - Interview with Oliver Sartor

June 25, 2018

Update on Bladder Cancer, Current Trials and Treatments - Bishoy Faltas

June 24, 2018

Updates in Advanced Urothelial Carcinoma - Highlights from ASCO 2018 - Petros Grivas

June 21, 2018

Dedication to Multidisciplinary Management of GU Oncology - Alex Kutikov

June 12, 2018

Nocturia & Lower Urinary Tract Conditions

Lower Urinary Tract Symptoms: Case-Based Discussion with Eric Rovner

June 6, 2018

Clinical Implications of the Abi Race Study: Interview with Dan George

June 5, 2018

Imaging Modality and Recommendations Included in RADAR 3: Interview with Phillip Koo

June 4, 2018

Personalization of Therapy to Optimize Outcomes for Men with Prostate Cancer - Interview with Felix Feng

June 1, 2018

The Men’s Eating and Living (MEAL) Study, Diet Intervention in Men on Active Surveillance for Prostate Cancer - Interview with J. Kellogg Parsons

May 21, 2018

Geriatric Assessment of Men with Prostate Cancer - Alicia Morgans

April 18, 2018

New Concepts in ADT- Thomas Keane

April 8, 2018

Advances in Bladder Cancer - Systemic Therapies Including Immunotherapy - Petros Grivas

April 8, 2018

EAU 2018 GU Oncology

M0 CRPC - Early Treatment Leading to Favorable Outcomes - Fred Saad.

March 22, 2018

EAU 2018 GU Oncology

Changing the Standard of Care in the M0 CRPC Patient: PROSPER - A Conversation with Cora Sternberg

March 25, 2018

M0 Prostate Cancer

SPARTAN: A Study of Apalutamide in Men with M0 Castration-Resistant Prostate Cancer M0 CRPC) - Alan Bryce

March 21, 2018

Defining Bladder Health - Ariana Smith

May 14, 2018

A Revolutionizing Time in Immuno-Oncology for Bladder Cancer - Neal Shore

March 14, 2018

EAU 2018 GU Oncology

Meeting an Unmet Need in the Nonmetastatic Castration Resistant Prostate Cancer Patient Population - Maha Hussain

March 19, 2018

Enobosarm in Postmenopausal Women for Stress Urinary Incontinence - Interview with Kenneth Peters

March 12, 2018

Nocturia & Lower Urinary Tract Conditions

Pathophysiology of Nocturia - Jeffrey Weiss

March 30, 2018

M0 Prostate Cancer

Changing the Landscape of nmCRPC - The SPARTAN Trial - Eric Small

March 6, 2018

Radical Prostatectomy for Patients with Oligometastatic Prostate Cancer - Robert Hamilton

March 5, 2018

Neoadjuvant Therapy for Men with High Risk Disease Prior to Prostatectomy - Mary-Ellen Taplin

February 23, 2018

Discussion on SPARTAN: A Study of Apalutamide in Men with Non-Metastatic Castration-resistant Prostate Cancer - Thomas Keane

February 14, 2018

GU OncToday/UroToday Book Club

Under the Knife, A Book Review with Kelly Parsons

January 22, 2018

GayBiProstate Study: Expanding Quality of Life and Understanding Sexual Function Post Treatment - Bernard Lee

January 19, 2018

UPWARD Study - Seizure Rates in Enzalutamide-Treated Men with mCRPC - Susan Slovin

January 6, 2018

News Update: Apalutamide as a Treatment for Non-Metastatic Castration-Resistant Prostate Cancer - Thomas Keane

January 3, 2018

Maelstrom: The Metabolic Syndrome in Men - Jeannette Potts

December 19, 2017

Seeking a Diagnosis with a Rising PSA - Jelle Barentsz

December 14, 2017

IRONMAN - A Better Understanding of the Variation in Care and Treatment - Daniel George

December 11, 2017

The Future of Targeted Alpha Therapy - Neal Shore

December 10, 2017

Navigating the Adverse Effects of ADT - Neal Shore

December 8, 2017

Biomarker Development in Advanced Prostate Cancer- Alicia Morgans

November 29, 2017

Cognitive Function and Hormone Therapy in Advanced Prostate Cancer - Interview with Alicia Morgans

November 13, 2017

RADAR II Group Recommendations - The Role of Therapeutic Layering

November 24, 2017

Clinical Genomic Risk Classification - Daniel Spratt

November 20, 2017

PRONOUNCE Trial: Cardiovascular Outcomes in Prostate Cancer - Susan Slovin

November 14, 2017

Role of MRI in Men on Active Surveillance - Laurence Klotz

November 14, 2017

When BCG Fails… Know All the Options - Gary Steinberg

November 14, 2017

Advanced Bladder Cancer Management: Immunotherapy - Interview with Arjun Balar

November 13, 2017

Imaging Controversies in Prostate Cancer- Interview with Phillip Koo

November 13, 2017

Genomic Testing and Hereditary Prostate Cancer- Interview with Leonard Gomella

November 13, 2017

Chemotherapy in Prostate Cancer: Why, When and How?-Interview with Fred Saad

November 13, 2017

Advanced Bladder Cancer Management: Immunotherapy - Establishing a Clinic of Excellence - Arjun Balar

November 12, 2017

Welcome Address for LUGPA 2017: Updates for Optimizing GU Oncology Cancer Clinics of Excellence - Neal Shore

November 11, 2017

Advanced Kidney Cancer Management for Urologists - Anil Kapoor

November 11, 2017

Chemotherapy in Prostate Cancer: Why, When and How? - Fred Saad

November 10, 2017

Sequencing and Combining CRPC Therapies: What Does the Future Hold? - Charles Ryan

November 10, 2017

Imaging Controversies for Prostate Cancer - Phillip Koo

November 10, 2017

Radiation: Prostate Cancer

SpaceOAR® Hydrogel Application Video -Marcio Fagundes

November 8, 2017

“Kegels In A Bottle”: Preliminary Results Of A Selective Androgen Receptor Modulator For The Treatment Of SUI - Kenneth Peters

October 19, 2017

'To Robot or Not to Robot’: Radical Cystectomy for Muscle-Invasive Bladder Cancer- Bernard Bochner

September 20, 2017

Impacts of Latitude and Stampede: Urologist and Urologic Oncologist's Perspective

September 18, 2017

Myths and Mysteries Surrounding Adjuvant Therapy for NMIBC - Ashish Kamat

September 19, 2017

Discussion on the AQUARiUS and EXCAAPE studies- Thomas Keane

October 15, 2017

Perspectives on Clinical Trial Design in NMIBC - Ashish Kamat

October 12, 2017

DNA Next Generation Sequence in the Prevention of Infectious Complications After Transrectal Prostate Biopsy - Vladimir Mouraviev

September 25, 2017

Prostate Cancer: Assorted Mortality Statistics - John Davis

September 25, 2017

Clinical Conversation: CHAARTED, LATITUDE and STAMPEDE

October 9, 2017

The Conundrum of Recurrent Low Grade Tumors - James McKiernan

October 10, 2017

ESMO 2017: Prostate Cancer Highlights

October 9, 2017

Immunotherapy of Advanced Bladder Cancer - Daniel Petrylak

September 7, 2017

Navigating the Adverse Effects of ADT: Improving Patient Outcomes - Jehonathan Pinthus and Neal Shore

October 2, 2017

Immune Checkpoint Inhibitors and the Effects on Anti-Tumor Response - Daniel Petrylak

September 26, 2017

GU OncToday/UroToday Book Club

'Life After the Diagnosis, Expert Advice on Living Well with Serious Illness for Patient and Caregivers' a conversation with Steven Pantilat & Charles Ryan.

September 25, 2017

Is the Evidence Sufficient to Recommend Statins for All Men With Prostate Cancer?- Lorelei Mucci

September 19, 2017

Bones, Hot Flashes and ADT: Using with Chemotherapy and Timing - Thomas Keane

September 1, 2017

ERAS and Radical Cystectomy - James McKiernan

August 9, 2017

Using Fluciclovine in the Recurrent Prostate Cancer Patient- David Schuster

August 21, 2017

Imaging Center

Struggling with Increased Sensitivity: PSMA PET/CT - Michael Hofman

August 16, 2017

Prostate Cancer and Molecular Tracers: 11C/18F-Choline for Biochemical Recurrence - Laura Evangelista

August 16, 2017

Kidney Cancer

Over-treatment of Renal Tumors: The Turtle in the Room - Robert G. Uzzo

August 9, 2017

The State of BPS/IC: "The Emperor Has No Clothes" - Christopher Payne

August 9, 2017

STAMPEDE and LATITUDE Trials: Issues to Consider - Thomas Keane

August 1, 2017

Plasma Based Biomarkers in Advanced Prostate Cancer - Gerhardt Attard

July 27, 2017

Radical Prostatectomy vs Radiation and ADT for Prostate Cancer: How Good is the Evidence? - Mack Roach

July 27, 2017

Oligometastatic and Oligo-progressive Prostate Cancer: Answer of the Nuclear Specialist - Stefano Fanti

July 27, 2017

Kidney Cancer

Adjuvant Therapies for Renal Cell Carcinoma - Robert Uzzo

July 21, 2017

Circulating Tumor Cells: Ready for Prime Time? - Interview with Howard Scher

July 17, 2017

APCCC 2017: Roundtable Discussion Neal Shore, Fred Saad & Charles Ryan

June 20, 2017

Patient-Reported Outcomes (PROs): Personalizing Care in Clinical Practice - Alicia Morgans

June 19, 2017

Using Biomarkers to Determine When Biopsy and When to Repeat the Biopsy- Stephen Williams

April 4, 2017

IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer- Lorelei Mucci

May 31, 2017

Definitive Cryotherapy for Localized Prostate Cancer - J Stephen Jones

May 11, 2017

Imaging Center

Multiparametric Prostate MRI: Current Status - Fergus Coakley

May 5, 2017

Perspective on Novel Agents - Including PARP Inhibitors - Christopher Logothetis

April 27, 2017

Perspective on Molecular Characterization - Himisha Beltran

April 27, 2017

AR-V7 Testing in Clinical Practice: Not Ready for Prime Time - Tomasz Beer

April 27, 2017

Managing the ‘Start’ and ‘Stop’ of Various Therapies for Treating CRPC Patients - Is Timing Everything?- Karim Fizazi

April 18, 2017

Update on Mechanisms of Resistance in Castration-Resistant Prostate Cancer- Karim Fizazi

January 31, 2017

ADT and the Mechanisms of Cardiovascular Disease- E. David Crawford

April 11, 2017

Pathological Information Needed From Radical Prostatectomy Specimen for Locally Advanced Disease: Margins, Lymph Nodes, and What Else? - Neal Shore

April 11, 2017

Systemic Treatment For Men With High Risk and Locally-Advanced Prostate Cancer Treated With Curative Intent- Nicholas James

April 7, 2017

Noel Clarke on Combination Treatment in Hormone-sensitive Prostate Cancer - STOP 6

February 14, 2017

Germline Mutations in Prostate Cancer - Salvatore Catarinicchia

February 11, 2017

MRI/US Fusion Prostate Biopsy - Mitchell Humphreys

July 25, 2016

Radiotherapy for Prostate Cancer: Hypofractionation of Radiation - Jason Efstathiou

June 14, 2016

Charles Ryan on mCRPC Treatment: Combination Therapy - Clinical Case

April 26, 2016

Detection of Metastatic Disease in Prostate Cancer: Past, Present, Future- Phillip Koo

April 21, 2016

Radiopharmaceuticals in Prostate Cancer - Stefano Fanti

April 1, 2016

Prostate Cancer: The Year in Review - Fred Saad

January 21, 2016